《Nature Communications》11月16日论文:宿主与铜绿假单胞菌共用嘧啶合成通路驱动囊性纤维化肺重塑,沉默DHODH使患者细胞增殖降约75%

哥伦比亚大学 Sebastian A. Riquelme 团队11月16日在《Nature Communications》发表论文,报告囊性纤维化(CF)气道细胞与主要病原体铜绿假单胞菌共用同一条嘧啶从头合成通路(DNPPS),共同驱动肺部重塑。囊性纤维化由 CFTR 基因突变引起,铜绿假单胞菌是其主要肺部病原体。
团队用来自3名患者与3名非患者供者的原代支气管上皮细胞实验发现,CF 细胞中该通路的限速酶 DHODH 水平升高。用小干扰RNA沉默 DHODH 后,CF 细胞的增殖被拉回正常水平,降幅约75%,而对非 CF 细胞影响很小。
转录组分析显示,CF 气道上皮细胞中上调的网络有34%与嘧啶代谢、异常细胞生长和纤维化相关。已获批的 DHODH 抑制剂来氟米特同样抑制了 CF 细胞增殖,外加尿苷可逆转这一效应;恢复 CFTR 功能的 ETI 三联疗法则使 CF 细胞生长正常化。
研究还发现,被宿主环境「驯化」的铜绿假单胞菌会上调自身的嘧啶合成机制,扩大生物量并释放维持重塑的因子。该研究为细胞与细菌层面的机制研究,实验在原代细胞与细胞系中完成,论文未报告人体临床试验,文中提出的干预策略尚待后续验证。
Nature Communications Paper on November 16: Shared Pyrimidine Synthesis Drives Cystic Fibrosis Lung Remodeling in Host and Pseudomonas Alike, and Silencing DHODH Cut Patient-Cell Growth by About 75%
A team led by Sebastian A. Riquelme at Columbia University published a paper on November 16 in Nature Communications reporting that cystic fibrosis (CF) airway cells and the major CF pathogen Pseudomonas aeruginosa share the same de novo pyrimidine synthesis pathway (DNPPS), which jointly drives lung remodeling. Cystic fibrosis is caused by mutations in the CFTR gene, and P. aeruginosa is its principal lung pathogen.
Working with primary bronchial epithelial cells from three patients and three non-CF donors, the team found elevated levels of DHODH, the pathway's rate-limiting enzyme, in CF cells. Silencing DHODH with small interfering RNA normalized CF cell proliferation, a reduction of about 75%, while exerting minimal effects on non-CF cells.
Transcriptomic analysis showed that 34% of all increased networks in CF airway epithelial cells related to pyrimidine metabolism, aberrant cell growth and fibrosis. Leflunomide, an approved DHODH inhibitor, likewise suppressed CF cell proliferation, an effect reversed by adding uridine, while restoring CFTR function with ETI triple therapy normalized CF cell growth.
The study also found that P. aeruginosa tolerized by the host environment upregulates its own pyrimidine synthesis machinery, amplifying its biomass and releasing factors that sustain remodeling. The work is a mechanistic study in primary cells and cell lines; the paper reports no human clinical trial, and the intervention strategies it proposes await further validation.
发布:GSM·美国(发布链接)
图片来源:Wikimedia Commons, File:Pseudomonas aeruginosa 01.jpg — Author: CDC. Licensing: Public domain.
GSM Global · 本篇英文版 English edition of this story

